National Association of Testing Authorities, Australia
Scope of Accreditation
Laverty Pathology
Site
Lingard Hospital Pathology Laboratory – Healius Pathology Pty Ltd
Accreditation No.
2203
Site No.
3089
Date of Accreditation
25 Feb 1991
Contact
Mr C Lord
P: +61 (02) 49298729
Availability
Services available to external clients
Supervision
B (Branch)
Scope of Accreditation
Lingard Hospital Pathology Laboratory – Healius Pathology Pty Ltd
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
29 Oct 2029
Last Activity Date
29 Apr 2026
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Digoxin; Vancomycin |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Blood; Plasma | Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Progesterone |
| Blood; Serum | Procalcitonin | |
| Plasma | Parathyroid hormone (PTH) | |
| Chemical pathology - Further investigation of cardiac function | Blood; Plasma | Troponin I |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Blood; Plasma | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Blood; Plasma | Uric acid |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood; Plasma | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase |
| Urine | Creatinine; Potassium; Sodium | |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); Fibrinogen; Prothrombin time (PT); Thrombin time (TT) |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Other blood group antibodies; Red blood cell phenotyping; Rh |
| Antibody elution | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies; Contamination - Microbiological |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood products | Compliance with transport, storage and distribution requirements of blood, products and components |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow-up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma | Human chorionic gonadotropin (hCG) - Quantitative total |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
29 Oct 2029
Last Activity Date
29 Apr 2026
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Glucose; Haemoglobin (Hb); Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
29 Oct 2029
Last Activity Date
29 Apr 2026
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Glucose; Haemoglobin (Hb); Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the Activities and Services covered by the Scope of Accreditation (SoA).
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
The Product column may also describe an Item or Material.
The Limitations column may also describe the Range.
Accreditation No.
2203
Site No.
3089
Print date
24 Aug 2026
END OF SCOPE